INViCARE revolutionizes infection control for implants using patented crystalline nanotechnology. We help professionals to provide optimal implant care.
INViCARE is a biotech company that aims to bring innovative biomaterials to the healthcare industry. Based on 7 years of collaborative research between McGill, Harvard, and University of Montreal, we have successfully developed a new class of nanomaterials with scientifically proven dental implant disinfection and bone healing properties. Our first product, NeoPhylaxis, is market-ready targeting infection control for dental implants.